Targeting phosphodiesterase 4 as a potential therapy for Parkinson's disease: a review.

Nongthombam, Pooja Devi; Haobam, Reena

Nongthombam, Pooja Devi; Haobam, Reena.

Affiliation

Nongthombam PD; Department of Biotechnology, Manipur University, Canchipur, Imphal, 795003, India.
Haobam R; Department of Biotechnology, Manipur University, Canchipur, Imphal, 795003, India. reena_haobam@rediffmail.com.

Mol Biol Rep ; 51(1): 510, 2024 Apr 15.

Article in En | MEDLINE | ID: mdl-38622307

Subject(s)

Diethylstilbestrol/analogs & derivatives; Neurodegenerative Diseases; Parkinson Disease; Phosphodiesterase 4 Inhibitors; Animals; Humans; Cyclic Nucleotide Phosphodiesterases, Type 4/metabolism; Parkinson Disease/drug therapy; Phosphodiesterase 4 Inhibitors/pharmacology; Phosphodiesterase 4 Inhibitors/therapeutic use; Cyclic AMP/metabolism; Neurodegenerative Diseases/metabolism; Cyclic GMP/metabolism; Mammals/metabolism

Key words

Apoptosis; Neurodegeneration; Neuroinflammation; Oxidative stress; Phosphodiesterase 4 inhibitors

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Neurodegenerative Diseases / Diethylstilbestrol / Phosphodiesterase 4 Inhibitors Limits: Animals / Humans Language: En Journal: Mol Biol Rep Year: 2024 Type: Article Affiliation country: India

Fulltext

XML

PubMed Links

Search on Google